Items

• Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort (2016-04)

  G. Foster, C. Coppola, M. Derbala, P. Ferenci, A. Verhaz, Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort, PLOS ONE, Vol. 11, No. 3, pp. 1 - 20, Apr, 2016